Traditionally, the treatment of type 2 diabetes has focused on blood glucose control and the prevention of complications. In the future, these therapeutic approaches could be complemented by another, which, according to current studies, could restore beta cell function and possibly lead to remission by targeting the reduction of glucotoxicity, lipotoxicity and insulin resistance.
Autoren
- Jens Dehn
Publikation
- InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
You May Also Like
- Psychooncology
Communication as the key to therapy adherence
- How do weight loss interventions affect the muscles?
Reflective evaluation: do not neglect qualitative aspects
- From biomarkers to gene therapies
Getting to know ataxias
- Evidence-based therapy for psoriasis in difficult locations
IL-23 inhibition in scalp psoriasis: what’s new?
- Obesity in the family practice
Aim for realistic goals and avoid apportioning blame
- Evidence, pathophysiology and management in the light of current data
Heart failure with improved ejection fraction (HFimpEF)
- Early rheumatoid arthritis
C1M has potential as a biomarker
- Osteoporosis